Source 1review2022Chemistry - An Asian Journal
Toolkit/light-responsive small molecule inhibitors
light-responsive small molecule inhibitors
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
small molecule inhibitors have been developed in which their OFF/ON therapeutic activity can be toggled using light
Usefulness & Problems
Why this is useful
These are small-molecule inhibitors whose therapeutic activity can be switched with light. The review presents them as tools for remote control of enzyme activity.; remote optical control of enzyme inhibition; studying target mechanisms in live cells and multicellular systems
Source:
These are small-molecule inhibitors whose therapeutic activity can be switched with light. The review presents them as tools for remote control of enzyme activity.
Source:
remote optical control of enzyme inhibition
Source:
studying target mechanisms in live cells and multicellular systems
Problem solved
They help probe underlying mechanisms of drug targets in live cells and multicellular systems with external control over inhibitor state. This can reduce confusion from constitutively active inhibitors.; adding reversible or externally controlled activity states to inhibitor function; reducing mechanistic ambiguity caused by uncontrolled inhibitor activity
Source:
They help probe underlying mechanisms of drug targets in live cells and multicellular systems with external control over inhibitor state. This can reduce confusion from constitutively active inhibitors.
Source:
adding reversible or externally controlled activity states to inhibitor function
Source:
reducing mechanistic ambiguity caused by uncontrolled inhibitor activity
Problem links
adding reversible or externally controlled activity states to inhibitor function
LiteratureThey help probe underlying mechanisms of drug targets in live cells and multicellular systems with external control over inhibitor state. This can reduce confusion from constitutively active inhibitors.
Source:
They help probe underlying mechanisms of drug targets in live cells and multicellular systems with external control over inhibitor state. This can reduce confusion from constitutively active inhibitors.
reducing mechanistic ambiguity caused by uncontrolled inhibitor activity
LiteratureThey help probe underlying mechanisms of drug targets in live cells and multicellular systems with external control over inhibitor state. This can reduce confusion from constitutively active inhibitors.
Source:
They help probe underlying mechanisms of drug targets in live cells and multicellular systems with external control over inhibitor state. This can reduce confusion from constitutively active inhibitors.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A reusable architecture pattern for arranging parts into an engineered system.
Techniques
No technique tags yet.
Target processes
No target processes tagged yet.
Input: Light
Implementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationimplementation constraint: spectral hardware requirementoperating role: actuator
They require a photosensitive inhibitor scaffold and a way to illuminate the system under study. The abstract does not specify exact chemistries or assay formats.; requires a light-responsive inhibitor design; requires optical access to the biological system
The abstract does not show that all selectivity issues are eliminated or that every enzymatic target is tractable. It also does not address pharmacokinetics or tissue penetration limits.; the abstract does not specify which inhibitor classes or targets are most effective; the abstract does not provide performance metrics or generality across enzymes
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
Photopharmacology uses light to modulate drugs and is being applied to selected enzymatic targets.
Light-responsive small-molecule inhibitors can toggle OFF and ON therapeutic activity using light.
Poor selectivity is a persistent challenge in drug development programs and can obscure mechanisms and modes of action.
Approval Evidence
1 source3 linked approval claimsfirst-pass slug light-responsive-small-molecule-inhibitors
small molecule inhibitors have been developed in which their OFF/ON therapeutic activity can be toggled using light
Source:
application scopesupports
Photopharmacology uses light to modulate drugs and is being applied to selected enzymatic targets.
Source:
capability summarysupports
Light-responsive small-molecule inhibitors can toggle OFF and ON therapeutic activity using light.
Source:
problem statementsupports
Poor selectivity is a persistent challenge in drug development programs and can obscure mechanisms and modes of action.
Source:
Comparisons
Source-stated alternatives
The abstract contrasts them implicitly with standard non-photoresponsive small-molecule inhibitors.
Source:
The abstract contrasts them implicitly with standard non-photoresponsive small-molecule inhibitors.
Source-backed strengths
activity can be toggled using light; supports study of drug targets in live cells and multicellular systems
Source:
activity can be toggled using light
Source:
supports study of drug targets in live cells and multicellular systems
Compared with mMORp
light-responsive small molecule inhibitors and mMORp address a similar problem space.
Shared frame: same top-level item type; same primary input modality: light
Compared with optogenetic probes
light-responsive small molecule inhibitors and optogenetic probes address a similar problem space.
Shared frame: same top-level item type; same primary input modality: light
Compared with organoid fusion
light-responsive small molecule inhibitors and organoid fusion address a similar problem space.
Shared frame: same top-level item type; same primary input modality: light
Ranked Citations
- 1.